4.6 Review

Heat Shock Factor 1 Inhibition: A Novel Anti-Cancer Strategy with Promise for Precision Oncology

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

Targeting HSF1 for cancer treatment: mechanisms and inhibitor development

Yeh Chin et al.

Summary: HSF1 is a master regulator of heat shock responsive signaling and also regulates a non-heat shock responsive transcriptional network. It plays important roles in cellular transformation and cancer development. Research on HSF1 has been active due to its critical functions in handling stressful cellular states. New functions and molecular mechanisms have been continuously discovered, providing new targets for cancer treatment strategies. This article reviews the essential roles and mechanisms of HSF1 in cancer cells, focusing on recently discovered functions and their underlying mechanisms, as well as advances in HSF1 inhibitors for cancer drug development.

THERANOSTICS (2023)

Review Biochemistry & Molecular Biology

Estrogen receptors as potential therapeutic target in endometrial cancer

Payel Guha et al.

Summary: Endometrial cancer is a common gynecological carcinoma worldwide, and its progression is driven by estrogen signaling through estrogen receptors (ERs) and G protein-coupled estrogen receptor (GPER). While the molecular aspects of ER-mediated signaling are partially understood, the role of GPER in endometrial malignancies remains unclear. Understanding the physiological roles of ERs and GPER in endometrial cancer biology can lead to the identification of potential therapeutic targets.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2023)

Article Oncology

ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis

Li He et al.

Summary: ErbB2 promotes the metastatic potential of breast cancer cells through HSF1/LDHA axis-mediated glycolysis. Targeting the HSF1/LDHA axis may be a promising strategy for treating breast cancer patients with ErbB2 overexpression.

MEDICAL ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Molecular mechanisms of heat shock factor 1 regulation

Szymon W. Kmiecik et al.

Summary: Cells need to maintain proteome homeostasis and regulate it through the heat shock response (HSR), which is orchestrated by heat shock transcription factor 1 (Hsf1). Hsf1 plays a crucial role in regulating proteome homeostasis and is involved in aging, cancer, and neurodegenerative disorders. Multiple layers of control circuits, such as synthesis and degradation, conformational rearrangements, post translational modifications (PTMs), and molecular chaperones in negative feedback loops, regulate the transcriptional activity of Hsf1.

TRENDS IN BIOCHEMICAL SCIENCES (2022)

Review Endocrinology & Metabolism

Estrogen Receptor Function: Impact on the Human Endometrium

Kun Yu et al.

Summary: This article discusses the role of estrogen in the female endometrium and its regulatory role through nuclear and membrane-associated receptors. The importance of ERs in maintaining endometrial function is emphasized, and references for treating endometrial diseases are provided.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Oncology

Heat Shock Proteins and HSF1 in Cancer

Anna M. Cyran et al.

Summary: The fitness of cells depends on the maintenance of protein homeostasis, which is achieved through the cooperative activities of protein chaperones and proteolytic machinery. In response to protein-damaging conditions, cells activate the heat-shock response (HSR) by upregulating a group of chaperones known as heat shock proteins (HSPs). Cancer cells, which experience high levels of proteotoxic stress, often upregulate major components of HSR, including HSF1 and individual HSPs. Elevated levels of HSPs and HSF1 are associated with drug resistance and poor clinical outcomes in various types of cancer. Targeting protein quality controls represents a promising approach for the treatment of human malignancies, as it can enhance the efficacy of standard and targeted chemotherapy as well as immune checkpoint inhibitors. In cancers with specific dependencies, HSR components can serve as alternative targets to oncogenic drivers that are difficult to drug.

FRONTIERS IN ONCOLOGY (2022)

Article Multidisciplinary Sciences

HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia

Qianze Dong et al.

Summary: The transcription factor HSF1 is specifically required for the maintenance of leukemia stem cells in acute myeloid leukemia (AML), and pharmacologically targeting HSF1 may have broad anti-leukemic effects.

NATURE COMMUNICATIONS (2022)

Review Biochemistry & Molecular Biology

An overview of signaling pathways regulating YAP/TAZ activity

Boon Chin Heng et al.

Summary: YAP and TAZ are crucial proteins involved in maintaining tissue/organ size and have diverse roles in various biological processes, including cell proliferation, tissue regeneration, cell fate determination, tumorigenesis, and mechanosensing.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Medicine, Research & Experimental

MicroRNA-615-5p regulates the proliferation and apoptosis of breast cancer cells by targeting HSF1

Kaisheng Liu et al.

Summary: MicroRNA-615-5p may mediate the progression of breast cancer by targeting HSF1. It regulates cell proliferation and apoptosis by modulating the expression of genes associated with proliferation and apoptosis.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biotechnology & Applied Microbiology

Increased HSF1 Promotes Infiltration and Metastasis in Cervical Cancer via Enhancing MTDH-VEGF-C Expression

Xueyan Shi et al.

Summary: The study demonstrates that HSF1 is overexpressed in cervical cancer, enhancing the expression of MTDH, VEGF-C, and CD31. It can bind to the MTDH promoter region to promote MTDH expression, and increase cell proliferation, migration, and invasion in cervical cancer cells. In vivo, interference with HSF1 inhibits tumor growth and reduces the expression of MTDH, VEGF-C, and CD31.

ONCOTARGETS AND THERAPY (2021)

Article Biology

Modulating HSF1 levels impacts expression of the estrogen receptor α and antiestrogen response

Maruhen A. D. Silveira et al.

Summary: High levels of heat shock factor 1 (HSF1) are associated with antiestrogen resistance in breast cancer cells, leading to ER alpha degradation and reduced expression of ER alpha-activated genes. However, reducing HSF1 levels can reinstate ER alpha expression and restore response to antiestrogens, suggesting that inhibiting HSF1 in combination with antiestrogens is a valid strategy to tackle resistant breast cancers.

LIFE SCIENCE ALLIANCE (2021)

Article Biology

Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells

Natalia Vydra et al.

Summary: Heat shock factor 1 (HSF1) is linked to estrogen (E2) signaling through estrogen receptor alpha (ER alpha), and its deficiency in ER-positive breast cancer cells may decrease ER alpha level, attenuate the mitogenic action of E2, reduce cell motility, and increase sensitivity to hormonal therapy and CDK4/6 inhibitors. Additionally, HSF1 enhances the genomic action of ER alpha in ER-positive breast cancer, and an elevated HSF1 level is associated with metastatic disease.

ELIFE (2021)

Article Cell Biology

LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy

Gaopeng Li et al.

Summary: Li et al. identified a lncRNA called LIMIT that regulates MHC-I expression through HSP90 and HSF1, impacting antitumour immune response and immunotherapy efficacy. By activating GBPs and MHC-I, LIMIT enhances tumour immunogenicity and boosts the effectiveness of immunotherapy.

NATURE CELL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

MED12 interacts with the heat-shock transcription factor HSF1 and recruits CDK8 to promote the heat-shock response in mammalian cells

Pratibha Srivastava et al.

Summary: The CKM module plays a crucial role in heat-shock transcription, promoting HSP70 expression through the kinase activity of CDK8 and CDK19, and maintaining proteostasis capacity to protect cells against proteotoxic stress.

FEBS LETTERS (2021)

Article Oncology

Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress

Zetian Shen et al.

Summary: This study evaluated the anti-tumor effect of co-inhibition of AURKA and HSF1 on hepatocellular carcinoma (HCC) cells, both in vitro and in vivo. The results showed that the combined inhibition led to increased cell apoptosis, potentially mediated by the endoplasmic reticulum stress (ERS) pathway. These findings suggest that AURKA and HSF1 may be promising targets for HCC treatment.

CELLULAR ONCOLOGY (2021)

Article Oncology

Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy

Rhiane Moody et al.

Summary: Autoantibodies recognizing phosphorylated heat shock factor 1 (HSF1-PO4) are proposed as potential new diagnostic biomarkers for early-stage high-grade serous ovarian cancer (HGSOC). Specific regions within HSF1 were identified, confirmed as useful biomarkers with comparable diagnostic potential to the full protein. Antibody responses to HSF1-PO4 and corresponding peptides increased post chemotherapy, suggesting these short peptide sequences could support early diagnosis or monitor responses to treatment.

CANCERS (2021)

Article Oncology

Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer

Sangah Lee et al.

Summary: The study identified HSF1 as a potential target protein to overcome EGFR-TKI resistance in NSCLC, demonstrating the efficacy of HSF1 inhibition in vitro and in vivo. This suggests a targetable HSF1 pathway to overcome multiple mechanisms of EGFR-TKI resistance.

CANCERS (2021)

Review Cell Biology

Role of NRF2 in Lung Cancer

Miriam Sanchez-Ortega et al.

Summary: The NRF2 transcription factor is crucial in cell defense responses against oxidative stress, but recent studies suggest that it may also promote tumor growth and metastasis in cancer, leading to a controversial discussion in the scientific community.

CELLS (2021)

Review Biochemistry & Molecular Biology

Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Karol Bukowski et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Emerging roles of HSF1 in cancer: Cellular and molecular episodes

Ge Wang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Article Multidisciplinary Sciences

The ABL2 kinase regulates an HSF1-dependent transcriptional program required for lung adenocarcinoma brain metastasis

Jacob P. Hoj et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Oncology

Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma

Miaomiao Li et al.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2020)

Review Oncology

Hsf1 on a leash - controlling the heat shock response by chaperone titration

Anna E. Masser et al.

EXPERIMENTAL CELL RESEARCH (2020)

Review Oncology

HSF1 as a Cancer Biomarker and Therapeutic Target

Richard L. Carpenter et al.

CURRENT CANCER DRUG TARGETS (2019)

Article Multidisciplinary Sciences

Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts

Nicola Ferrari et al.

NATURE COMMUNICATIONS (2019)

Review Pharmacology & Pharmacy

Inhibiting Heat Shock Factor 1 in Cancer: A Unique Therapeutic Opportunity

Bushu Dong et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2019)

Review Cell Biology

Regulation of heat shock transcription factors and their roles in physiology and disease

Rocio Gomez-Pastor et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Article Oncology

HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target

Jacqueline H. L. Fok et al.

CLINICAL CANCER RESEARCH (2018)

Review Oncology

Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment

Belinda van Zyl et al.

ENDOCRINE-RELATED CANCER (2018)

Article Biochemistry & Molecular Biology

The estrogen-related receptors in metabolism and cancer: newer insights

Harmit S. Ranhotra

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2018)

Article Pharmacology & Pharmacy

Effect of BIS depletion on HSF1-dependent transcriptional activation in A549 non-small cell lung cancer cells

Hye Hyeon Yun et al.

KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

High-throughput discovery of functional disordered regions: investigation of transactivation domains

Charles N. J. Ravarani et al.

MOLECULAR SYSTEMS BIOLOGY (2018)

Article Biotechnology & Applied Microbiology

Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients

Tao Wan et al.

ONCOTARGETS AND THERAPY (2018)

Review Biochemistry & Molecular Biology

Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics

Chiranjeev Sharma et al.

MOLECULES (2018)

Review Oncology

Cell Origins of High-Grade Serous Ovarian Cancer

Jaeyeon Kim et al.

CANCERS (2018)

Article Oncology

Autoantibodies against HSF1 and CCDC155 as Biomarkers of Early-Stage, High-Grade Serous Ovarian Cancer

Amy L. Wilson et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)

Review Biochemistry & Molecular Biology

Regulation of the mammalian heat shock factor 1

Sharadha Dayalan Naidu et al.

FEBS JOURNAL (2017)

Article Biochemistry & Molecular Biology

New inhibitor targeting human transcription factor HSF1: effects on the heat shock response and tumor cell survival

Nuria Vilaboa et al.

NUCLEIC ACIDS RESEARCH (2017)

Review Cell Biology

Rethinking HSF1 in Stress, Development, and Organismal Health

Jian Li et al.

TRENDS IN CELL BIOLOGY (2017)

Article Multidisciplinary Sciences

The HSF1-PARP13-PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis

Mitsuaki Fujimoto et al.

NATURE COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

KRIBB11 accelerates Mcl-1 degradation through an HSF1-independent, Mule-dependent pathway in A549 non-small cell lung cancer cells

Min-Jung Kang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

Selective killing of cancer cells by small molecules targeting heat shock stress response

Daniel Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor

Shintaro Iwasaki et al.

NATURE (2016)

Article Biochemistry & Molecular Biology

Structure of human heat-shock transcription factor 1 in complex with DNA

Tobias Neudegger et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)

Review Cell Biology

HSF1 Guardian of Proteostasis in Cancer

Chengkai Dai et al.

TRENDS IN CELL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Structure of human heat-shock transcription factor 1 in complex with DNA

Tobias Neudegger et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)

Article Biochemistry & Molecular Biology

ERK-mediated phosphorylation of BIS regulates nuclear translocation of HSF1 under oxidative stress

Hye Yun Kim et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2016)

Article Chemistry, Medicinal

Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approach

Jeanette R. McConnell et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Article Oncology

Sensitizing tumor cells to radiation by targeting the heat shock response

Daniela Schilling et al.

CANCER LETTERS (2015)

Review Medicine, Research & Experimental

Targeting the adaptive molecular landscape of castration-resistant prostate cancer

Alexander W. Wyatt et al.

EMBO MOLECULAR MEDICINE (2015)

Review Oncology

Multifaceted roles of HSF1 in cancer

Sufang Jiang et al.

TUMOR BIOLOGY (2015)

Review Oncology

Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

Philip A. Watson et al.

NATURE REVIEWS CANCER (2015)

Article Biochemistry & Molecular Biology

The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy

Ruth Scherz-Shouval et al.

Article Hematology

The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma

Tanja Heimberger et al.

BRITISH JOURNAL OF HAEMATOLOGY (2013)

Article Biochemistry & Molecular Biology

KNK437, abrogates hypoxia-induced radioresistance by dual targeting of the AKT and HIF-1α survival pathways

Deepu Oommen et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)

Review Biochemistry & Molecular Biology

Regulation of HSF1 Function in the Heat Stress Response: Implications in Aging and Disease

Julius Anckar et al.

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)

Article Multidisciplinary Sciences

High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer

Sandro Santagata et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Biochemistry & Molecular Biology

The Heat Shock Response: Life on the Verge of Death

Klaus Richter et al.

MOLECULAR CELL (2010)

Review Cell Biology

Heat shock factors: integrators of cell stress, development and lifespan

Malin Akerfelt et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)

Review Pharmacology & Pharmacy

Inhibiting the transcription factor HSF1 as an anticancer strategy

Luke Whitesell et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2009)

Article Multidisciplinary Sciences

Stress-Inducible Regulation of Heat Shock Factor 1 by the Deacetylase SIRT1

Sandy D. Westerheide et al.

SCIENCE (2009)

Article Biochemistry & Molecular Biology

Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis

Chengkai Dai et al.